SCHEMBL13420811

SCHEMBL13420811

C/C=C1/[C@H](O)C[C@H]2[C@@H]3CCC4C[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GRIN1 Q05586 4/20 0.42
▸ GRIN2B Q13224 4/20 0.42
▸ MAPK1 P28482 3/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ G6PD P11413 1/20 0.39
▸ GRIN2D O15399 1/20 0.39
▸ GRIN2A Q12879 1/20 0.39
▸ GRIN2C Q14957 1/20 0.39
▸ GPBAR1 Q8TDU6 3/20 0.38
▸ LMNA P02545 2/20 0.38
▸ SHBG P04278 2/20 0.38
▸ SERPINA6 P08185 2/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ HSD17B3 P37058 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ PMP22 Q01453 1/20 0.38
▸ KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3220822 1.00 GRIN1 (0.42) GRIN1GRIN2BMAPK1ALDH1A1TP53
SCHEMBL13420394 1.00 GRIN1 (0.42) GRIN1GRIN2BMAPK1ALDH1A1TP53
SCHEMBL7425466 0.82 GRIN1 (0.58) GRIN1GRIN2BMAPK1ALDH1A1TP53
SCHEMBL13420386 0.82 GRIN1 (0.58) GRIN1GRIN2BMAPK1ALDH1A1TP53
SCHEMBL13420804 0.82 GRIN1 (0.58) GRIN1GRIN2BMAPK1ALDH1A1TP53
SCHEMBL3202646 0.82 GRIN1 (0.58) GRIN1GRIN2BMAPK1ALDH1A1TP53
SCHEMBL25322998 0.81 LMNA (0.59) GRIN1GRIN2BGRIN2DGRIN2AGRIN2C
SCHEMBL25323572 0.81 LMNA (0.59) GRIN1GRIN2BGRIN2DGRIN2AGRIN2C
SCHEMBL25912457 0.81 LMNA (0.59) GRIN1GRIN2BGRIN2DGRIN2AGRIN2C
SCHEMBL25326883 0.81 LMNA (0.59) GRIN1GRIN2BGRIN2DGRIN2AGRIN2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056487-A1 MODULATORS OF AMYLOID-BETA PRODUCTION SATORI PHARMACEUTICALS, INC. (US) 2010-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056487-A1 MODULATORS OF AMYLOID-BETA PRODUCTION APP, BACE1, BACE2 GRIN1 1118/4885GRIN2B 683/4885MAPK1 4259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback